ORLANDO — Genetic testing is warranted in patients with epilepsy of unknown origin, new research suggests. Investigators found that pathogenic genetic variants were identified in over 40% of patients ...

STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Biogen (Nasdaq: BIIB), Praxis Precision Medicines ...

A simple scoring system from researchers at Rutgers Health and other institutions may help doctors predict which patients will likely become seizure-free after minimally invasive epilepsy surgery. A ...

Noninvasive tests performed in midlife may help identify people who are at risk of late-onset epilepsy (LOE), a new study suggests. New data from the Framingham Heart Study show those who scored ...

More than ever before, people with epilepsy are living normal lives. The key is to get treatment, typically a medication, for seizures—the unpredictable disruptions in the brain's electrical system ...